Benton CS, Miller BH, Skwerer S, Suzuki O, Schultz LE, Cameron MD, Marron JS, Pletcher MT, Wiltshire T. Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains.
Psychopharmacology (Berl). 2012 May;221(2):297-315. Epub 2011 Nov 24.
Tim Wiltshire University of North Carolina, Chapel Hill, NC|
Mathew T Pletcher Pfizer Global Research and Development, Groton, CT
|Participants||Benton CS, Miller BH, Skwerer S, Suzuki O, Schultz LE, Cameron MD, Marron JS|
|Contact||Tim Wiltshire email@example.com
|Part of a series:||
Behavior phenotype data see Pletcher1
• Behavior phenotype data (fluoxetine study) see Wiltshire2
• Neurobiochemical analyte data (this project) Wiltshire3
|Acknowledgements||Funding provided by NIH MH077251 and MH084528; State of Florida |
In fulfillment of NIH requirements that all information is made promptly and freely available to the research community, data are deposited in the MPD when complete.
|Phenotype strain survey data set|
|MPD identifiers||Wiltshire3 MPD:381|
|No updates/corrections. Initial release date: 12/2011.|
Click above to copy-paste the entire citation for this MPD web page.
|Summary of procedures that were conducted|
|• biomarker quantification||Brain tissue survey of 30 biochemical analytes. Fluoxetine-treated vs. control. 21d.|